Additional file 2: Figure S2. of Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease – cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort

Martin Busch (523317)
Jennifer Nadal (3479210)
Matthias Schmid (51150)
Katharina Paul (686395)
Stephanie Titze (825259)
Silvia Hübner (721164)
Anna Köttgen (3111024)
Ulla Schultheiss (3479207)
Seema Baid-Agrawal (3479201)
Johan Lorenzen (319945)
Georg Schlieper (721165)
Claudia Sommerer (3153246)
Vera Krane (135094)
Robert Hilge (3479204)
Jan Kielstein (3479198)
Florian Kronenberg (87557)
Christoph Wanner (156898)
Kai-Uwe Eckardt (186164)
Gunter Wolf (2679817)

Publication date

June 2016

DOI

10.6084/m9.figshare.c.3616166_d2.v1

Abstract

Association between hemoglobin and estimated glomerular filtration rate (eGFR) in 1759 patients having diabetes mellitus and stage 3 chronic kidney disease and/or overt proteinuria (r = 0.247, p < 0.0001). (PPT 103 kb

Extracted data

We use cookies to provide a better user experience.

Data Protection

Additional file 2: Figure S2. of Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease – cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort

Martin Busch (523317)
Jennifer Nadal (3479210)
Matthias Schmid (51150)
Katharina Paul (686395)
Stephanie Titze (825259)
Silvia Hübner (721164)
Anna Köttgen (3111024)
Ulla Schultheiss (3479207)
Seema Baid-Agrawal (3479201)
Johan Lorenzen (319945)
Georg Schlieper (721165)
Claudia Sommerer (3153246)
Vera Krane (135094)
Robert Hilge (3479204)
Jan Kielstein (3479198)
Florian Kronenberg (87557)
Christoph Wanner (156898)
Kai-Uwe Eckardt (186164)
Gunter Wolf (2679817)

Open link

Publication date

June 2016

DOI

10.6084/m9.figshare.c.3616166_d2.v1

Abstract

Extracted data

Macdougall, Iain C.
Bock, Andreas H.
Carrera, Fernando
Eckardt, Kai-Uwe
Gaillard, Carlo
Van Wyck, David
Meier, Yvonne
Larroque, Sylvain
Roger, Simon D.
Groningen Kidney Center (GKC)

January 2017

(a) Ferritin and (b) transferrin saturation (TSAT) for patients with eGFR values at baseline and mon...

Additional file 4: Figure S2. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial

Macdougall, Iain C.
Bock, Andreas H.
Carrera, Fernando
Eckardt, Kai-Uwe
Gaillard, Carlo
Van Wyck, David
Meier, Yvonne
Larroque, Sylvain
Roger, Simon D.
Groningen Kidney Center (GKC)

January 2017

(a) Ferritin and (b) transferrin saturation (TSAT) for patients with eGFR values at baseline and mon...

Additional file 4: Figure S2. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial

Iain Macdougall (3560840)
Andreas Bock (44151)
Fernando Carrera (2825312)
Kai-Uwe Eckardt (186164)
Carlo Gaillard (3473609)
David Van Wyck (3661405)
Yvonne Meier (2825321)
Sylvain Larroque (703653)
Simon Roger (3661408)

January 2017

(a) Ferritin and (b) transferrin saturation (TSAT) for patients with eGFR values at baseline and mon...

Additional file 5: Table S3. of Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease – cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort

Martin Busch (523317)
Jennifer Nadal (3479210)
Matthias Schmid (51150)
Katharina Paul (686395)
Stephanie Titze (825259)
Silvia Hübner (721164)
Anna Köttgen (3111024)
Ulla Schultheiss (3479207)
Seema Baid-Agrawal (3479201)
Johan Lorenzen (319945)
Georg Schlieper (721165)
Claudia Sommerer (3153246)
Vera Krane (135094)
Robert Hilge (3479204)
Jan Kielstein (3479198)
Florian Kronenberg (87557)
Christoph Wanner (156898)
Kai-Uwe Eckardt (186164)
Gunter Wolf (2679817)

June 2016

Correlates of median HbA1C levels >7.0 % (53 mmol/mol) including the most frequently used antidiabet...

Additional file 2: of Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes

Antonio Mirijello (4818981)
Francesca Viazzi (675398)
Paola Fioretto (3935144)
Carlo Giorda (327489)
Antonio Ceriello (60179)
Giuspina Russo (6051023)
Pietro Guida (3935147)
Roberto Pontremoli (675396)
Salvatore Cosmo (5577164)

December 2018

Table S2. Baseline clinical characteristics of patients grouped by eGFR and albuminuria. (DOCX 19 kb

Additional file 2: of Prescribing of diabetes medications to people with type 2 diabetes and chronic kidney disease: a national cross-sectional study

Jo-Anne Manski-Nankervis (6157178)
Sharmala Thuraisingam (4540357)
Janet Sluggett (4764273)
Gary Kilov (4767870)
John Furler (3497654)
David OâNeal (6375131)
Alicia Jenkins (804281)

February 2019

Table S2. Prescription of non-insulin diabetes medications by eGFR for patients with average eGFR <6...

Additional file 2: Figure S2. of Diabetic kidney disease in the elderly: prevalence and clinical correlates

Giuseppina Russo (3190596)
Salvatore De Cosmo (158567)
Francesca Viazzi (675398)
Antonio Mirijello (4818981)
Antonio Ceriello (60179)
Pietro Guida (3935147)
Carlo Giorda (327489)
Domenico Cucinotta (409603)
Roberto Pontremoli (675396)
Paola Fioretto (3935144)

February 2018

Odds Ratios with 99.9% confidence interval (CI) of Q Score groups for eGFR< 60 mL/min/1.73 m2 or alb...

Additional file 1: Figure S1. of Diabetic kidney disease in the elderly: prevalence and clinical correlates

Giuseppina Russo (3190596)
Salvatore De Cosmo (158567)
Francesca Viazzi (675398)
Antonio Mirijello (4818981)
Antonio Ceriello (60179)
Pietro Guida (3935147)
Carlo Giorda (327489)
Domenico Cucinotta (409603)
Roberto Pontremoli (675396)
Paola Fioretto (3935144)

February 2018

Odds Ratios with 99.9% confidence interval (CI) for eGFR< 60 mL/min/1.73 m2 (2A) or albuminuria (2B)...

MOESM2 of Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases

Peter Bramlage (79720)
Stefanie Lanzinger (4379524)
Gesine Mark (6473075)
Eva Hess (6473078)
Simon Fahrner (6473081)
Christoph Heyer (6473084)
Mathias Friebe (6473087)
Jochen Seufert (802034)
Thomas Danne (3543587)
Reinhard Holl (4831683)

March 2019

Additional file 2: Table S2. Drug treatment by comorbidity. Legend: Percent (%). ‡Defined as eGFR < ...

Additional file 3 of Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidence

Meir Schechter (8637279)
Cheli Melzer-Cohen (6277318)
Aliza Rozenberg (10073015)
Ilan Yanuv (10073012)
Gabriel Chodick (362030)
Avraham Karasik (4530457)
Mikhail Kosiborod (6021260)
Ofri Mosenzon (11194789)

August 2021

Additional file 3: Figure S2. Risk for cardiovascular and kidney outcomes in SGLT2i initiators compa...

Additional file 4: Figure S2. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial

Macdougall, Iain C.
Bock, Andreas H.
Carrera, Fernando
Eckardt, Kai-Uwe
Gaillard, Carlo
Van Wyck, David
Meier, Yvonne
Larroque, Sylvain
Roger, Simon D.
Groningen Kidney Center (GKC)

January 2017

(a) Ferritin and (b) transferrin saturation (TSAT) for patients with eGFR values at baseline and mon...

Additional file 4: Figure S2. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial

Macdougall, Iain C.
Bock, Andreas H.
Carrera, Fernando
Eckardt, Kai-Uwe
Gaillard, Carlo
Van Wyck, David
Meier, Yvonne
Larroque, Sylvain
Roger, Simon D.
Groningen Kidney Center (GKC)

January 2017

(a) Ferritin and (b) transferrin saturation (TSAT) for patients with eGFR values at baseline and mon...

Additional file 4: Figure S2. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial

Macdougall, Iain C.
Bock, Andreas H.
Carrera, Fernando
Eckardt, Kai-Uwe
Gaillard, Carlo
Van Wyck, David
Meier, Yvonne
Larroque, Sylvain
Roger, Simon D.
Groningen Kidney Center (GKC)
NHS Foundation Trust
Department of Nephrology, Kantonsspital Aarau
Eurodial, Da Vita
University of Erlangen-Nuremberg
DaVita Healthcare Partners Inc.
P.O. Box 8152
Renal Research

January 2017

(a) Ferritin and (b) transferrin saturation (TSAT) for patients with eGFR values at baseline and mon...

Additional file 4: Figure S2. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial

Macdougall, Iain C.
Bock, Andreas H.
Carrera, Fernando
Eckardt, Kai-Uwe
Gaillard, Carlo
Van Wyck, David
Meier, Yvonne
Larroque, Sylvain
Roger, Simon D.
Groningen Kidney Center (GKC)
NHS Foundation Trust
Department of Nephrology, Kantonsspital Aarau
Eurodial, Da Vita
University of Erlangen-Nuremberg
DaVita Healthcare Partners Inc.
P.O. Box 8152
Renal Research

January 2017

(a) Ferritin and (b) transferrin saturation (TSAT) for patients with eGFR values at baseline and mon...

Additional file 4: Figure S2. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial

Macdougall, Iain C.
Bock, Andreas H.
Carrera, Fernando
Eckardt, Kai-Uwe
Gaillard, Carlo
Van Wyck, David
Meier, Yvonne
Larroque, Sylvain
Roger, Simon D.
Groningen Kidney Center (GKC)

January 2017

(a) Ferritin and (b) transferrin saturation (TSAT) for patients with eGFR values at baseline and mon...

Additional file 4: Figure S2. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial

Macdougall, Iain C.
Bock, Andreas H.
Carrera, Fernando
Eckardt, Kai-Uwe
Gaillard, Carlo
Van Wyck, David
Meier, Yvonne
Larroque, Sylvain
Roger, Simon D.
Groningen Kidney Center (GKC)

January 2017

(a) Ferritin and (b) transferrin saturation (TSAT) for patients with eGFR values at baseline and mon...

Additional file 4: Figure S2. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial

Iain Macdougall (3560840)
Andreas Bock (44151)
Fernando Carrera (2825312)
Kai-Uwe Eckardt (186164)
Carlo Gaillard (3473609)
David Van Wyck (3661405)
Yvonne Meier (2825321)
Sylvain Larroque (703653)
Simon Roger (3661408)

January 2017

(a) Ferritin and (b) transferrin saturation (TSAT) for patients with eGFR values at baseline and mon...

Martin Busch (523317)
Jennifer Nadal (3479210)
Matthias Schmid (51150)
Katharina Paul (686395)
Stephanie Titze (825259)
Silvia Hübner (721164)
Anna Köttgen (3111024)
Ulla Schultheiss (3479207)
Seema Baid-Agrawal (3479201)
Johan Lorenzen (319945)
Georg Schlieper (721165)
Claudia Sommerer (3153246)
Vera Krane (135094)
Robert Hilge (3479204)
Jan Kielstein (3479198)
Florian Kronenberg (87557)
Christoph Wanner (156898)
Kai-Uwe Eckardt (186164)
Gunter Wolf (2679817)

June 2016

Correlates of median HbA1C levels >7.0 % (53 mmol/mol) including the most frequently used antidiabet...

Additional file 2: of Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes

Antonio Mirijello (4818981)
Francesca Viazzi (675398)
Paola Fioretto (3935144)
Carlo Giorda (327489)
Antonio Ceriello (60179)
Giuspina Russo (6051023)
Pietro Guida (3935147)
Roberto Pontremoli (675396)
Salvatore Cosmo (5577164)

December 2018

Table S2. Baseline clinical characteristics of patients grouped by eGFR and albuminuria. (DOCX 19 kb

Additional file 2: of Prescribing of diabetes medications to people with type 2 diabetes and chronic kidney disease: a national cross-sectional study

Jo-Anne Manski-Nankervis (6157178)
Sharmala Thuraisingam (4540357)
Janet Sluggett (4764273)
Gary Kilov (4767870)
John Furler (3497654)
David OâNeal (6375131)
Alicia Jenkins (804281)

February 2019

Table S2. Prescription of non-insulin diabetes medications by eGFR for patients with average eGFR <6...

Additional file 2: Figure S2. of Diabetic kidney disease in the elderly: prevalence and clinical correlates

Giuseppina Russo (3190596)
Salvatore De Cosmo (158567)
Francesca Viazzi (675398)
Antonio Mirijello (4818981)
Antonio Ceriello (60179)
Pietro Guida (3935147)
Carlo Giorda (327489)
Domenico Cucinotta (409603)
Roberto Pontremoli (675396)
Paola Fioretto (3935144)

February 2018

Odds Ratios with 99.9% confidence interval (CI) of Q Score groups for eGFR< 60 mL/min/1.73 m2 or alb...

Additional file 1: Figure S1. of Diabetic kidney disease in the elderly: prevalence and clinical correlates

Giuseppina Russo (3190596)
Salvatore De Cosmo (158567)
Francesca Viazzi (675398)
Antonio Mirijello (4818981)
Antonio Ceriello (60179)
Pietro Guida (3935147)
Carlo Giorda (327489)
Domenico Cucinotta (409603)
Roberto Pontremoli (675396)
Paola Fioretto (3935144)

February 2018

Odds Ratios with 99.9% confidence interval (CI) for eGFR< 60 mL/min/1.73 m2 (2A) or albuminuria (2B)...

MOESM2 of Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases

Peter Bramlage (79720)
Stefanie Lanzinger (4379524)
Gesine Mark (6473075)
Eva Hess (6473078)
Simon Fahrner (6473081)
Christoph Heyer (6473084)
Mathias Friebe (6473087)
Jochen Seufert (802034)
Thomas Danne (3543587)
Reinhard Holl (4831683)

March 2019

Additional file 2: Table S2. Drug treatment by comorbidity. Legend: Percent (%). ‡Defined as eGFR < ...

Additional file 3 of Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidence

Meir Schechter (8637279)
Cheli Melzer-Cohen (6277318)
Aliza Rozenberg (10073015)
Ilan Yanuv (10073012)
Gabriel Chodick (362030)
Avraham Karasik (4530457)
Mikhail Kosiborod (6021260)
Ofri Mosenzon (11194789)

August 2021

Additional file 3: Figure S2. Risk for cardiovascular and kidney outcomes in SGLT2i initiators compa...

Additional file 4: Figure S2. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial

Macdougall, Iain C.
Bock, Andreas H.
Carrera, Fernando
Eckardt, Kai-Uwe
Gaillard, Carlo
Van Wyck, David
Meier, Yvonne
Larroque, Sylvain
Roger, Simon D.
Groningen Kidney Center (GKC)

January 2017

(a) Ferritin and (b) transferrin saturation (TSAT) for patients with eGFR values at baseline and mon...

Additional file 4: Figure S2. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial

Macdougall, Iain C.
Bock, Andreas H.
Carrera, Fernando
Eckardt, Kai-Uwe
Gaillard, Carlo
Van Wyck, David
Meier, Yvonne
Larroque, Sylvain
Roger, Simon D.
Groningen Kidney Center (GKC)

January 2017

(a) Ferritin and (b) transferrin saturation (TSAT) for patients with eGFR values at baseline and mon...

Additional file 4: Figure S2. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial

Macdougall, Iain C.
Bock, Andreas H.
Carrera, Fernando
Eckardt, Kai-Uwe
Gaillard, Carlo
Van Wyck, David
Meier, Yvonne
Larroque, Sylvain
Roger, Simon D.
Groningen Kidney Center (GKC)
NHS Foundation Trust
Department of Nephrology, Kantonsspital Aarau
Eurodial, Da Vita
University of Erlangen-Nuremberg
DaVita Healthcare Partners Inc.
P.O. Box 8152
Renal Research

January 2017

(a) Ferritin and (b) transferrin saturation (TSAT) for patients with eGFR values at baseline and mon...

Additional file 4: Figure S2. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial

Macdougall, Iain C.
Bock, Andreas H.
Carrera, Fernando
Eckardt, Kai-Uwe
Gaillard, Carlo
Van Wyck, David
Meier, Yvonne
Larroque, Sylvain
Roger, Simon D.
Groningen Kidney Center (GKC)
NHS Foundation Trust
Department of Nephrology, Kantonsspital Aarau
Eurodial, Da Vita
University of Erlangen-Nuremberg
DaVita Healthcare Partners Inc.
P.O. Box 8152
Renal Research

January 2017

(a) Ferritin and (b) transferrin saturation (TSAT) for patients with eGFR values at baseline and mon...

Additional file 4: Figure S2. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial

Macdougall, Iain C.
Bock, Andreas H.
Carrera, Fernando
Eckardt, Kai-Uwe
Gaillard, Carlo
Van Wyck, David
Meier, Yvonne
Larroque, Sylvain
Roger, Simon D.
Groningen Kidney Center (GKC)

January 2017

(a) Ferritin and (b) transferrin saturation (TSAT) for patients with eGFR values at baseline and mon...

Additional file 4: Figure S2. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial

Macdougall, Iain C.
Bock, Andreas H.
Carrera, Fernando
Eckardt, Kai-Uwe
Gaillard, Carlo
Van Wyck, David
Meier, Yvonne
Larroque, Sylvain
Roger, Simon D.
Groningen Kidney Center (GKC)

January 2017

(a) Ferritin and (b) transferrin saturation (TSAT) for patients with eGFR values at baseline and mon...

Additional file 4: Figure S2. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial

Iain Macdougall (3560840)
Andreas Bock (44151)
Fernando Carrera (2825312)
Kai-Uwe Eckardt (186164)
Carlo Gaillard (3473609)
David Van Wyck (3661405)
Yvonne Meier (2825321)
Sylvain Larroque (703653)
Simon Roger (3661408)

January 2017

(a) Ferritin and (b) transferrin saturation (TSAT) for patients with eGFR values at baseline and mon...

Additional file 2: Figure S2. of Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease – cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort

Abstract

Extracted data

Additional file 2: Figure S2. of Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease – cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort

Abstract

Extracted data

Related items

Related items